ESSILORLUXOTTICA USA INC.

Lobbying for ESSILORLUXOTTICA USA INC. · Vision care and eyewear.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate · $130,000.00 expenses · posted Apr 11, 2025

Lobbying activity 1

Health Issues

Introduction to EssilorLuxottica; Med-tech innovations; Combating Organized Retail Crime Act (CORCA); Issues related to Myopia education

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.